Capital Flow Monitor · Sponsors · CIK 1903671
Glycologix, Inc.
100 CUMMINGS CENTER, SUITE 451C, BEVERLY, MA, 01915 · 6174802536
Other Technology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$1.0M
Sold
$800K
% sold
80.0%
Investors
30
Min investment
$1
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-29 | D ·current | 506(b) | $1.0M | $800K | 80.0% | 30 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Daniel Deardorf — Executive Officer / Director, Beverly, MA
- George Adaniya — Director, Beverly, MA
-
Michael Chester — Director, Beverly, MA
1 other raise
- Chester Capital I LLC $0 of $20.0M · 0.0%
- Martha Farmer — Director, Beverly, MA
-
Michael Marsh — Director, Beverly, MA
4 other raises
- Sterling Lane Fund I, LP $0 of —
- Flexxbotics, Inc. $5.9M of —
- Bagels & Co. $5.3M of $5.5M · 95.9%
- SemiNex Corp $3.1M of $3.5M · 88.2%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.